Trademark: OFEZUMIR 2353852
Word
OFEZUMIR
ID
2353852
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
31 March 2023
Registration Date
31 March 2023
Renewal Date
31 March 2033
Owner(s)
Incyte Holdings Corporation
Service
Goods and Services:
Class 5:
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders.
Class 16:
Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building.
Class 44:
Providing a medical information to healthcare providers and patients relating to viral, hematological, auto-immune, graft versus host, inflammatory, metabolic and dermatological disorders.

Trademark Alertz ® - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by IP Australia. Copyright of the trademark data resides with IP Australia. ipaustralia.gov.au